目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 INCLUSIONS AND EXCLUSIONS
1.3.2 MARKETS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY DATA
2.1.2.1 KEY DATA FROM PRIMARY SOURCES
2.1.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.3 MARET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
2.8 IMPACT OF ECONOMIC RECESSION

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.3 ADJACENT TECHNOLOGIES
5.4 INDUSTRY TRENDS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 PORTER'S FIVE FORCE ANALYSIS
5.8 TARIFF AND REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
5.9 PATENT ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
5.11 KEY CONFERENCES & EVENTS DURING 2023-2024
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS & BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 HS CODES FOR PEN NEEDLES
5.14 ECOSYSTEM/MARKET MAP
5.15 ADJACENT MARKET ANALYSIS
5.16 UNMET NEEDS ANALYSIS/END USER EXPECTATIONS
5.17 AI IN PEN INJECTORS
5.18 CASE STUDY ANALYSIS

6 PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
6.1 INTRODCUTION
6.2 STANDARD PEN NEEDLES
6.3 SAFETY PEN NEEDLES

7 PEN NEEDLES MARKET, BY LENGTH, 2021-2028 (USD MILLION)
7.1 INTRODCUTION
7.2 8MM
7.3 5MM
7.4 6MM
7.5 4MM
7.5 12MM
7.5 10MM

8 PEN NEEDLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
8.1 INTRODUCTION
8.2 INSULIN THERAPY
8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY
8.3 GROWTH HORMONE THERAPY
8.4 OSTEOPOROSIS (ABOLOPARATIDE, TERIPARATIDE THERAPY)
8.5 OTHER APPLICATIONS

9 PEN NEEDLES MARKET, BY END USER, 2021-2028 (USD MILLION)
9.1 INTRODUCTION
9.2 PATIENTS/HOME CARE
9.3 HOSPITALS AND CLINICS
9.4 OTHER END USERS

10 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2021-2028 (USD MILLION)
10.1 INTRODUCTION
10.2 PRESCRIPTION-BASED
10.3 OVER THE COUNTER (OTC)
10.4 ONLINE PURCHASE
10.5 OTHER MODES OF PURCHASE

11 PEN NEEDLES MARKET, BY REGION, 2021-2028 (USD MILLION)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 IMPACT OF ECONOMIC RECESSION
11.2.2 US
11.2.3 CANADA
11.3 EUROPE
11.3.1 IMPACT OF ECONOMIC RECESSION
11.3.2 GERMANY
11.3.3 FRANCE
11.3.4 UK
11.3.5 ITALY
11.3.6 SPAIN
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 IMPACT OF ECONOMIC RECESSION
11.4.2 JAPAN
11.4.3 CHINA
11.4.4 AUSTRALIA & NEW ZEALAND
11.4.5 INDIA
11.4.6 SOUTH KOREA
11.4.7 SOUTHEAST ASIA
11.4.8 ROAPAC
11.5 LATIN AMERICA
11.5.1 IMPACT OF ECONOMIC RECESSION
11.5.2 BRAZIL
11.5.3 MEXICO
11.5.4 ARGENTINA
11.5.5 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 IMPACT OF ECONOMIC RECESSION

12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
12.4 COMPANY EVALUATION MATRIX
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
12.4.5 COMPANY FOOTPRINT
12.5 START-UP/SME EVALUATION MATRIX
12.5.1 PROGRESSIVE COMPANIES
12.5.2 RESPONSIVE COMPANIES
12.5.3 DYNAMIC COMPANIES
12.5.4 STARTING BLOCKS
12.5.5 COMPETITIVE BENCHMARKING
12.6 MARKET SHARE ANALYSIS
12.7 COMPETITIVE SITUATION AND TRENDS
12.7.1 PRODUCT LAUNCHES & APPROVALS
12.7.2 DEALS
12.7.3 OTHER DEVELOPMENTS

13 COMPANY PROFILE
13.1 KEY PLAYERS
13.1.1 EMBECTA CORP.
13.1.2 NOVO NORDISK A/S
13 1.3 YPSOMED HOLDING AG
13.1.4 B. BRAUN MELSUNGEN AG
13.1.5 TERUMO CORPORATION
13.1.6 NIPRO CORPORATION
13.1.7 OWEN MUMFORD
13.1.8 ARKRAY
13.1.9 ULTIMED
13.1.10 HINDUSTAN SYRINGES AND MEDICAL DEVICES
13.1.11 MONTMED
13.1.12 HTL-STREFA
13.1.13 ALLISON MEDICAL, INC.
13.1.14 GLUCORX
13.1.15 BERPU MEDICAL TECHNOLOGY
13.1.16 ADVACARE PHARMA
13.1.17 ARTSANA GROUP
13.1.18 PROMISEMED DIABETES CARE
13.1.19 TRIVIDIA HEALTH
13.1.20 VOGT MEDICAL VERTRIEB
13.2 OTHER PLAYERS
13.2.1 VAN HEEK MEDICAL
13.2.2 SIMPLE DIAGNOSTICS
13.2.3 IYON
13.2.4 LINKS MEDICAL PRODUCTS
13.2.5 MHC MEDICAL PRODUCTS

14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS